More than 314,000 children in the U.S. live with type 1 diabetes (T1D), with thousands of new cases identified every year. It is the most common chronic disease affecting children, yet for many, diagnosis comes only after a medical emergency. With the recently released SPOT-T1D Kids clinical pathway, tools, and implementation guide, Ariadne Labs is… Continue reading Ariadne Labs Releases SPOT-T1D Kids Solution for Earlier Type 1 Diabetes Detection
These adaptable tools support primary care practices in universal T1D screening and ongoing monitoring. Explore clinician conversation guides, clinical protocols, family handouts, and result resources organized by audience and pathway moment.
The SPOT-T1D Kids Implementation Guide and embedded toolkit of resources provides evidence-based guidance for primary care teams to plan, launch, improve, and sustain pediatric type 1 diabetes (T1D) autoantibody screening and monitoring in their clinics.
Francine Maloney, MPH and Umila Singh, MFA author a perspective published by Breakthrough T1D on the development of the recently released SPOT-T1D Kids clinical pathway, tools, and implementation guide.
Twenty years after the Surgical Safety Checklist transformed patient safety around the world, Ariadne Labs is helping shape what’s next. Nearly 20 years after the introduction of the World Health Organization Surgical Safety Checklist transformed operating rooms around the world, Ariadne Labs is helping lead a new international effort to ensure surgical safety continues to… Continue reading Ariadne Labs Helps Lead Global Partnership to Shape the Future of Surgical Safety
The NIH-funded network will implement and scale population-based genomic screening for common, actionable conditions in 25,000 adults in primary care settings across the U.S. Researchers at Ariadne Labs, a joint center for health systems innovation at Brigham and Women’s Hospital and the Harvard T.H. Chan School of Public Health, and partner institutions have received a… Continue reading Ariadne Labs and Collaborators Receive NIH Funding to Launch Major National Study Advancing Population Genomic Screening in Primary Care
Ariadne Labs is pleased to announce the appointment of Jason Vassy, MD, MPH, MS, as Director of Precision Population Health, ushering in the next chapter of the program’s work to advance the responsible and equitable integration of genomic medicine into health care. Dr. Vassy is a clinician-investigator at the VA Boston Healthcare System and Brigham… Continue reading Ariadne Labs Announces Jason Vassy as Director of Precision Population Health Program